2m 2m 2m 2m 2m 2m 2m
Nexstar Med Grp (NXST)
NASDAQ
$167.20+$3.19 (+1.95%)
Price as of Jun 23, 2026 4:23 PM EDT- $5.0BMarket Cap
- -2.64%1-Year Change
- BroadcastingIndustry
Nexstar Med Grp (NXST)
$167.20+$3.19 (+1.95%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.9B -8.47% | 5.4B +9.61% | 4.9B -5.33% | 5.2B +12.10% | |
Cost of Revenue | 2.2B +0.63% | 2.2B +3.16% | 2.2B +7.39% | 2.0B +7.65% | |
Gross Profit | 2.7B -14.81% | 3.2B +14.60% | 2.8B -13.29% | 3.2B +15.08% | |
Sales and Marketing Expense | 1.1B -2.30% | 1.1B -0.73% | 1.1B -0.54% | 1.1B +7.58% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 471.0M -41.71% | 808.0M -14.13% | 941.0M +42.12% | 662.1M +120.03% | |
Total Operating Expenses | 4.1B -0.94% | 4.1B -2.04% | 4.2B +8.36% | 3.9B +12.26% | |
Operating Profit | 849.0M -33.04% | 1.3B +79.10% | 708.0M -46.04% | 1.3B +11.63% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -444.0M -0.67% | -447.0M +32.80% | -336.6M +19.09% | |
Interest Income and Expense and Net | 0 +100.00% | -444.0M -0.67% | -447.0M +32.80% | -336.6M +19.09% | |
Total Nonoperating Income and Expense | N/A N/A | -2.0M -71.43% | -7.0M -7.89% | -7.6M +339.05% | |
Income before Taxes | 150.0M -84.36% | 959.0M +139.15% | 401.0M -67.05% | 1.2B +11.32% | |
Income Taxes | 67.0M -75.72% | 276.0M +110.69% | 131.0M -52.12% | 273.6M +4.08% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 109.0M -84.90% | 722.0M +108.67% | 346.0M -64.37% | 971.1M +16.36% | |
Net Income from Continuing Operations Applicable to Common | 150.0M -84.36% | 959.0M +139.15% | 401.0M -67.05% | 1.2B +11.32% | |
Basic EPS and Net Income | 3.04 -86.01% | 21.73 +122.19% | 9.78 -60.37% | 24.68 +24.58% | |
Diluted EPS and Net Income | 3.00 -85.99% | 21.41 +122.10% | 9.64 -60.10% | 24.16 +27.29% | |
Basic Weighted Average Shares | 30.3M -6.07% | 32.3M -8.51% | 35.3M -10.25% | 39.3M -6.61% | |
Diluted Weighted Average Shares | 30.7M -6.37% | 32.8M -8.48% | 35.8M -10.83% | 40.2M -8.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 280.0M +94.44% | 144.0M +6.67% | 135.0M -33.86% | 204.1M +6.93% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 280.0M +94.44% | 144.0M +6.67% | 135.0M -33.86% | 204.1M +6.93% | |
Total Current Assets | 1.5B +13.57% | 1.3B -11.53% | 1.5B -9.20% | 1.6B +14.28% | |
Accumulated Depreciation | 1.1B +7.47% | 1.0B +11.87% | 910.0M +9.01% | 834.8M +13.11% | |
Property and Plant and Equipment and Net | 1.2B -4.06% | 1.2B -4.89% | 1.3B +0.52% | 1.3B -16.53% | |
Total Long-Term Assets | 373.0M -4.11% | 389.0M +0.78% | 386.0M +2.20% | 377.7M -4.67% | |
Total Assets | 10.8B -5.42% | 11.5B -5.05% | 12.1B -4.74% | 12.7B -4.41% | |
Income Taxes Payable | 1.4B -8.94% | 1.5B -2.17% | 1.5B -5.33% | 1.6B -7.11% | |
Total Short-Term Debt | 111.0M -10.48% | 124.0M 0.00% | 124.0M -0.24% | 124.3M +163.51% | |
Total Current Liabilities | 711.0M -9.20% | 783.0M -18.52% | 961.0M +7.59% | 893.2M +13.45% | |
Total Long-Term Debt | 6.2B -2.77% | 6.4B -4.68% | 6.7B -1.67% | 6.8B -7.34% | |
Total Long-Term Liabilities | 497.0M -6.40% | 531.0M -7.01% | 571.0M -2.16% | 583.6M +11.53% | |
Total Liabilities | 8.8B -4.52% | 9.2B -5.79% | 9.8B -1.46% | 9.9B -4.78% | |
Retained Earnings | 3.5B -3.65% | 3.7B +15.15% | 3.2B +5.11% | 3.0B +37.61% | |
Total Stockholders Equity | 2.1B -8.55% | 2.3B -1.83% | 2.3B -16.13% | 2.7B -3.84% | |
Total Shares Outstanding | 30.3M -35.86% | 47.3M 0.00% | 47.3M 0.00% | 47.3M -0.02% | |
Cash Flow | |||||
Cash from Operating Activities | 891.0M -28.72% | 1.3B +25.13% | 999.0M -28.80% | 1.4B +15.49% | |
Capital Expenditures | 148.0M +2.07% | 145.0M -2.68% | 149.0M -5.28% | 157.3M +4.34% | |
Cash from Investing Activities | -173.0M +69.61% | -102.0M -41.04% | -173.0M -238.18% | 125.2M +153.94% | |
Dividends Paid | 226.0M +3.20% | 219.0M +14.66% | 191.0M +34.32% | 142.2M +20.30% | |
Cash from Financing Activities | -582.0M -49.44% | -1.2B +28.03% | -899.0M -40.66% | -1.5B +60.22% | |
Financials Ratio | |||||
Gross Margin | 54.84% -6.93% | 58.92% +4.56% | 56.36% -8.41% | 61.53% +2.66% | |
Operating Margin | 17.16% -26.85% | 23.45% +63.40% | 14.35% -43.00% | 25.18% -0.42% | |
Return on Assets | 0.98% -84.07% | 6.13% +119.40% | 2.80% -62.66% | 7.49% +19.61% | |
Return on Equity | 5.05% -84.08% | 31.69% +130.84% | 13.73% -60.47% | 34.74% +11.73% | |
Revenue Growth | -8.47% -188.15% | 9.61% +280.11% | -5.33% -144.08% | 12.10% +270.37% | |
Current Ratio | 2.07 +25.07% | 1.66 +8.58% | 1.53 -15.60% | 1.81 +0.73% | |
Cash Ratio | 0.39 +114.14% | 0.18 +30.89% | 0.14 -38.51% | 0.23 -5.73% | |
Debt-to-Equity Ratio | 3.07 +6.17% | 2.89 -2.82% | 2.97 +17.26% | 2.54 -2.51% | |
Debt-to-Assets Ratio | 0.58 +2.65% | 0.57 +0.48% | 0.57 +3.25% | 0.55 -1.91% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow